PSA "undetectible" for amost a year
The fourth consecutive PSA result came back at <0.02 ng/mL, nearly one year after surgery.
Four consecutive undetectable PSAs over nearly a year are certainly reassuring and indicate that there is currently no detectable biochemical recurrence. However, they do not mean it is “all clear.” They also do not erase my longer-term recurrence risk given my adverse pathology and biology: Gleason 3+4, pT3b with seminal-vesicle involvement, extracapsular extension, lymphovascular and perineural invasion, and a high Decipher score.
For now, I plan to continue with my current strategy of regular PSA monitoring and reserving salvage radiation for a confirmed rising PSA rather than automatically pursuing adjuvant radiation. Why subject myself to treatment and its potential side effects before I need it? If there is roughly a 50% chance that I will not experience a recurrence, why undergo treatment now that may ultimately never be necessary?
I’m encouraged by the continued undetectable PSA and, as always, I welcome any and all input from the group.
Interested in more discussions like this? Go to the Prostate Cancer Support Group.
Connect

@notpetecrowarmstrong
The article does discuss the higher risk based on the PSA in this section.
Elevated risk of all-cause mortality was significant for all PSA cutpoints above 0.25 ng/mL through 0.50 ng/mL. At the 0.50 ng/mL cutpoint, the adjusted hazard ratio was 1.61 (95% CI = 1.21–2.14, P = .001).
Recommendation for ADT in higher risk cases is discussed in a lot of other places. I captured this information from an article that referenced the link I included. The only thing missing seems to be the recommendation for ADT above .5 which other articles like the one mentioned below recommend ADT when PSA level before SRT was ≥0.7. I know there are articles that discuss the .5 recommendation for ADT but it’s been a long time since I captured that information.
ADT combined with SRT appears to improve OS in patients with a PSA level before SRT of ≥0.7 ng/mL. In patients without persistent PSA after prostatectomy and PSA levels of <0.7 ng/mL, ADT should not routinely be used, but may be considered in patients with additional risk factors such as Gleason Score ≥8 and negative surgical margins.
Discussed here
https://pmc.ncbi.nlm.nih.gov/articles/PMC12170276/
@carbcounter
The answer to this question Is based on the treatment the person received.
If someone gets a prostatectomy then the PSA should stay undetectable. If It reaches .2 It is considered a case of reoccurrence and should be treated with radiation. There are a few cases where people have reached .2 and it just stayed there.
When it comes to radiation treatment for prostate cancer, the standard is that they don’t treat until the PSA reaches two points above the lowest it ever reached following radiation. If after radiation, it hit .1 then they would not treat until it hits 2.1. It would make sense to do a PSMA PET scan after it hits 1 since it is more likely to show if a Metastasis is causing the rise.
-
Like -
Helpful -
Hug
1 Reaction@jeffmarc
Thanks for responding. At .041 my current PSA number is significantly less than .2. If it gets as high as .2 I hope my urologist recommends radiation.
@johnfinch
Sorry that I misread your .041 as .41. It is definitely low at this point. You have a while before it even reaches .2 if it does. At least now you know what the options are for getting treated.
When my PSA hit .2 after a prostatectomy, I was given a Lupon shot and two months later had salvage radiation. That’s sort of the ideal treatment, They didn’t have PSMA PET scans back then. Today you can have a scan and see if something shows up that can be zapped before SRT.
-
Like -
Helpful -
Hug
1 Reaction@jeffmarc So they don't do radiation until two points higher, but they maintain or restart the hormone blockers much more strictly, I gather, that's really what I have questions about. I see questions here about this all the time.
As @soli says, after complete removal I can see the point.
@jeffmarc Thanks, Jeff. I appreciate you sharing your experience and your .
insights.